# Metabolic Modulation as Treatment in Acute Heart Failure

> **NCT00449423** · PHASE2 · TERMINATED · sponsor: **University of Aarhus** · enrollment: 32 (estimated)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** acipimox

## Key facts

- **NCT ID:** NCT00449423
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 32 (ESTIMATED)
- **Why stopped:** due to slow recruitment
- **Last updated:** 2007-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449423, "Metabolic Modulation as Treatment in Acute Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00449423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*